Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Henry

Showing results (1161-1170 of 1,277) with videos related to

Pageof 128
Sort By:
Journal of the American College of Cardiology|August 29, 2015
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary InterventionPhilippe Généreux, Gennaro Giustino, Bernhard Witzenbichler, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
Circulation|October 13, 2021
Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart AssociationAlice K Jacobs, Murtuza J Ali, Patricia J Best, et al.
Circulation. Cardiovascular Interventions|October 14, 2015
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES StudyGiora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.
The Canadian Journal of Cardiology|January 29, 2026
Defining Population at Risk and Assessment of Patients with Presumed Coronary Microvascular and Vasomotor DysfunctionLaurie-Anne Boivin-Proulx, Erick Schampaert, Kevin Bainey, et al.
Circulation. Cardiovascular Interventions|December 21, 2018
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting StentsAkiko Maehara, Gary S Mintz, Bernhard Witzenbichler, et al.
ESC Heart Failure|October 23, 2020
Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomesJozef Bartunek, Andre Terzic, Beth A Davison, et al.
Cardiovascular Research|August 13, 2021
Recommendations for nomenclature and definition of cell products intended for human cardiovascular useDoris A Taylor, Lourdes Chacon-Alberty, Luiz C Sampaio, et al.
European Journal of Heart Failure|April 9, 2026
AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: Rationale and study design of the GenePHIT trialT D Henry, E S Chung, M Alvisi, et al.
Circulation|August 4, 2007
A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarctionTimothy D Henry, Scott W Sharkey, M Nicholas Burke, et al.
Pageof 128

Showing results (1161-1170 of 1,277) with videos related to

Sort By:
Pageof 128
Journal of the American College of Cardiology|August 29, 2015
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary InterventionPhilippe Généreux, Gennaro Giustino, Bernhard Witzenbichler, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
Circulation|October 13, 2021
Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart AssociationAlice K Jacobs, Murtuza J Ali, Patricia J Best, et al.
Circulation. Cardiovascular Interventions|October 14, 2015
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES StudyGiora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.
The Canadian Journal of Cardiology|January 29, 2026
Defining Population at Risk and Assessment of Patients with Presumed Coronary Microvascular and Vasomotor DysfunctionLaurie-Anne Boivin-Proulx, Erick Schampaert, Kevin Bainey, et al.
Circulation. Cardiovascular Interventions|December 21, 2018
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting StentsAkiko Maehara, Gary S Mintz, Bernhard Witzenbichler, et al.
ESC Heart Failure|October 23, 2020
Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomesJozef Bartunek, Andre Terzic, Beth A Davison, et al.
Cardiovascular Research|August 13, 2021
Recommendations for nomenclature and definition of cell products intended for human cardiovascular useDoris A Taylor, Lourdes Chacon-Alberty, Luiz C Sampaio, et al.
European Journal of Heart Failure|April 9, 2026
AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: Rationale and study design of the GenePHIT trialT D Henry, E S Chung, M Alvisi, et al.
Circulation|August 4, 2007
A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarctionTimothy D Henry, Scott W Sharkey, M Nicholas Burke, et al.
Pageof 128